THYMOGLOBULIN
THYMOGLOBULIN
Approved
DIN Number
02246805
Drug Class
Human
Market Date
May 6, 2003
Company
HC
sanofi-aventis canada inc
Product Information
Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.
Product Details
Health Canada regulatory and product classification information
Regulatory Identifiers
DIN Number02246805
AIG Number0148686001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Schedule D
,
Prescription
A
ATC Code
L04AA04 ANTITHYMOCYTE IMMUNOGLOBULIN (RABBIT)
Product Specifications
Dosage FormPowder For Solution
Route of AdministrationIntravenous
AHFS Classification90:28.16.92
Health Canada Classification
ACTIVE INGREDIENTS (1)
ANTI-THYMOCYTE GLOBULIN (RABBIT)Active
Strength: 25 MG / VIAL
Monograph: ANTI-THYMOCYTE GLOBULIN (RABBIT)